eXoZymes, Inc.
EXOZ
$7.80
-$0.82-9.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 25.31% | 47.90% | 78.68% | 97.86% | 161.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.69% | 63.79% | 82.53% | 117.97% | 167.04% |
| Operating Income | -47.69% | -63.79% | -82.50% | -117.93% | -168.17% |
| Income Before Tax | -45.73% | -58.05% | -64.22% | -95.53% | -142.78% |
| Income Tax Expenses | -- | -- | -104.73% | -104.73% | -100.00% |
| Earnings from Continuing Operations | -44.17% | -56.25% | -62.76% | -93.30% | -139.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.17% | -56.25% | -62.76% | -93.30% | -139.12% |
| EBIT | -47.69% | -63.79% | -82.50% | -117.93% | -168.17% |
| EBITDA | -49.43% | -66.44% | -86.57% | -124.92% | -181.07% |
| EPS Basic | -21.25% | -22.94% | -24.57% | -58.80% | -111.40% |
| Normalized Basic EPS | -22.55% | -24.36% | -25.72% | -60.69% | -114.73% |
| EPS Diluted | -21.25% | -22.94% | -24.57% | -58.80% | -111.40% |
| Normalized Diluted EPS | -22.55% | -24.36% | -25.72% | -60.69% | -114.73% |
| Average Basic Shares Outstanding | 18.49% | 27.70% | 30.51% | 21.98% | 13.48% |
| Average Diluted Shares Outstanding | 18.49% | 27.70% | 30.51% | 21.98% | 13.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |